drugset / Trial / NCT02064062

Autologous Stem Cells in Achilles Tendinopathy

NCT02064062 ↗

Phase 2 Unknown 10 enrolled University College, London
NaSingle-groupOpen-labelTreatment

Summary

This study is looking at a new treatment, using the patient's own stem cells (the repair cells of the body), to see whether this can help reduce pain and promote healing of the Achilles tendon, without side effects.

Timeline

Start
2015-01
Primary completion
2018-12
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous mesenchymal stem cells Cell therapy — Other

Indications